Company Valuation: Dr. Reddy's Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 714,500 767,655 1,024,969 953,168 1,044,616 1,020,098 - -
Change - 7.44% 33.52% -7.01% 9.59% -2.35% - -
Enterprise Value (EV) 1 703,980 719,330 960,383 928,633 1,011,902 989,686 966,202 941,001
Change - 2.18% 33.51% -3.31% 8.97% -2.2% -2.37% -2.61%
P/E 30.4x 17.1x 18.4x 16.9x 24.4x 27.4x 21x 17.8x
PBR 3.76x 3.33x 3.63x 2.86x 2.78x 2.5x 2.27x 2.06x
PEG - 0.2x 0.8x 13.12x -1x -2.1x 0.7x 1x
Capitalization / Revenue 3.33x 3.11x 3.67x 2.93x 3.11x 2.9x 2.59x 2.36x
EV / Revenue 3.28x 2.92x 3.44x 2.85x 3.01x 2.82x 2.46x 2.18x
EV / EBITDA 13.7x 11.1x 12.1x 10.8x 15.1x 15.7x 12x 10.2x
EV / EBIT 20.5x 13.8x 14.8x 13.4x 21.8x 23.4x 16.8x 13.8x
EV / FCF 52.3x 15.1x 33.1x 49.1x 30.3x 27.4x 29.4x 22.4x
FCF Yield 1.91% 6.61% 3.02% 2.04% 3.3% 3.65% 3.4% 4.46%
Dividend per Share 2 6 8 8 8 8 8.143 8.693 9.515
Rate of return 0.7% 0.87% 0.65% 0.7% 0.64% 0.67% 0.71% 0.78%
EPS 2 28.34 54.18 66.92 67.78 51.42 44.74 58.32 68.84
Distribution rate 21.2% 14.8% 12% 11.8% 15.6% 18.2% 14.9% 13.8%
Net sales 1 214,391 246,697 279,164 325,535 335,933 351,218 393,490 432,490
EBITDA 1 51,400 64,559 79,481 86,236 67,048 63,231 80,606 92,298
EBIT 1 34,277 52,057 64,781 69,178 46,443 42,269 57,505 68,125
Net income 1 23,568 45,073 55,779 56,544 42,850 37,128 49,221 58,020
Net Debt 1 -10,520 -48,325 -64,586 -24,535 -32,714 -30,412 -53,896 -79,097
Reference price 2 861.08 924.30 1,231.03 1,144.05 1,254.65 1,224.50 1,224.50 1,224.50
Nbr of stocks (in thousands) 829,771 830,526 832,611 833,152 832,596 833,073 - -
Announcement Date 5/19/22 A 5/10/23 A 5/7/24 A 5/9/25 A 5/12/26 A - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
27.84x2.83x16.27x0.63% 10.75B
37.06x13.1x27.8x0.54% 1,135B
38.61x6.49x18.27x2.02% 635B
36.46x8.38x17.33x2.41% 505B
20.87x5.11x12.73x2.56% 378B
105.89x5.92x25.41x2.34% 358B
21.76x5.68x13.94x2.81% 295B
22.43x4.53x12.94x1.95% 266B
27.87x7.16x12.81x2.3% 237B
-45.48x6.98x27.06x2.11% 193B
Average 29.33x 6.62x 18.46x 1.97% 401.44B
Weighted average by Cap. 35.21x 8.28x 20.38x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Dr. Reddy's Laboratories Limited

Historical PBR trend

Valuation ratios - PBR - Dr. Reddy's Laboratories Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Dr. Reddy's Laboratories Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Dr. Reddy's Laboratories Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock
  4. Valuation Dr. Reddy's Laboratories Limited